Alternatives to Animals in Research

Animal studies are an indispensable tool for understanding complex living organisms. At UW–Madison, scientists are devoted to the highest standards of research ethics and always prioritize non-animal methods for conducting research.

UW–Madison has long been committed to the ethical principle and practice of animal research’s three R’s: replacement, reduction, and refinement. “Replacement” means that whenever a non-animal method can answer their research questions, UW–Madison scientists use these methods instead of animal models.  (The other two R’s are “reduction,” minimizing the number of animals in any study, and “refinement,” minimizing the discomfort of and lasting effects on animals in research.)

Cutting-edge alternatives to animal studies are also a priority for federal agencies that guide taxpayer-funded scientific research and technology development. These methods are often referred to as “NAMs” — short for “new approach methodologies,” “non-animal methods,” “non-animal models,” “novel alternative methods” or similar phrases.

NAMs are not a single technology or method for conducting research. Rather, they are a group of approaches that complement — and, in some instances, replace — animals in research, because they lead to scientific outcomes that adequately substitute for whole living organisms.

Many NAMs incorporate human or other animal cells — ranging from single cells or groups of individual types of cells to communities of different types of cells that mimic tissue from specific parts of the body or act like particular organs (sometimes called organoids). NAMs like these may be used in several forms, including in small devices sometimes referred to “tissue on a chip” or “organ on a chip,” or floating free in test tubes or grown on scaffolding to represent three-dimensional human tissue. These NAMs are often used to study the way disease develops, the way cells interact, and the way healthy or damaged tissue responds to potential toxins or new drugs.

UW–Madison researchers at the Wisconsin National Primate Research Center and School of Veterinary Medicine helped these types of NAMs take a leap forward when they isolated stem cells in non-human primates and then in humans, and then by developing methods to coax human stem cells into scores of different types of cells, including specialized cells that make up parts of brains, hearts, muscles, eyes, blood and more.

Modeling living systems with computers — including using AI and machine learning techniques — represents another type of NAM. Computer models are helping researchers sift through large collections of data to zero in on molecules with shapes and behaviors that make them promising drug candidates and to narrow down particular genes that may contribute to disease. Some computer models can help predict how certain chemicals move around the body or the cancer risk those chemicals might present.

NAMs like these are common tools in UW–Madison labs, where new NAMs are also under development.

However, NAMs cannot yet fully replicate the complexity of living organisms. The way an immune system or developmental changes influence how a disease progresses or how a new drug candidate affects both its target and other parts of the body involve too many unknowns and intricacies to be modeled reliably and safely with NAMs. And many newer NAMs or NAMs under development intended to complement or replace animal studies will still require validation using animal models, so that scientists can be certain these alternative methods are delivering relevant results that accurately reflect the biology of living individuals. Validation can pave the way for research using new NAMs that leads to safe clinical trials or studies in humans.

That is why UW–Madison remains committed to using and developing NAMs and to safe and responsible research with animals when animal models are necessary — supported by specially trained scientists, veterinarians and animal care staff and conducted under the oversight of federal agencies and in accordance with federal regulations.